Table 2 Microbiologic profile
From: Surgical treatment on infective endocarditis: impact of diabetes on mortality
Group I (Non-DM patients) | Group II (DM patients) | ||
|---|---|---|---|
N | 326 | 94 | |
Staphylococcus aureus (n, %) | 109 (33.4%) | 42 (44.7%) | 0.320 |
Coagulase-negative Staphylococcus (n, %) | 26 (8%) | 7 (7.4%) | |
Enterococcus (n, %) | 75 (23%) | 19 (20.2%) | 0.433 |
Streptococcus species (n, %) | 89 (27.3%) | 16 (17%) | 0.063 |
HACEK (n, %) | 3 (0.9%) | 2 (2.1%) | 0.454 |
Fungus (n, %) | 1 (0.3%) | 1 (1%) | 0.121 |
Coxiella burnetti (n, %) | 9 (2.8%) | 2 (2.1%) | 0.786 |
Gram-negative bacteria (n, %) | 1 (0.3%) | 1 (1%) | 0.090 |
Negative cultures (n, %) | 13 (4%) | 4 (4.3%) | 0.237 |